Working to Eradicate Gynecologic Cancers

Eileen Banaga, MD

Investigator
AREVA Med
4800 Hampden Lane, Suite 200
Bethesda, MD
USA 20814

Papers:
157 Long term safety follow up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab